Genentech accepts Roche takeover bid at $95 a share

Date: Thu, 12 Mar 2009 12:01:09 -0400

Genentech accepts Roche takeover bid at $95 a share

Roche and Genentech end their protracted takeover effort with a
friendly accord under which the Basel health care major will pay $95 a
share for the 44% of the South San Francisco biotech giant it doesn't
already own.

GEITHNER FRETS THAT GLOBAL STIMULUS PLANS WILL PETER OUT TOO SOON

Spending plans that major countries around the globe have put in place
to combat the worldwide recession may not have the staying power to
make it to the late rounds of the crisis, says Treasury Secretary
Timothy Geithner.